Novo Nordisk today announced positive topline results from PIONEER TEENS, a phase 3a trial evaluating oral semaglutide for type 2 diabetes in children and adolescents aged 10–17 years with type 2 diabetes. Oral semaglutide demonstrated a superior reduction in HbA1c (a measure of blood sugar
therapy
High in Oman’s Green Mountain, where fresh air and dramatic views create a natural sanctuary, guests will soon have the chance to experience one of Eastern wellness’s most renowned therapies under the guidance of an internationally recognised specialist. From 16 November to 15 December 2025, Jala Spa & Wellness at Hotel Indigo Jabal Akhdar Resort […]
Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the primary overall survival (OS) analysis of the Phase 3 monarchE trial. Treatment with two years of Verzenio plus endocrine therapy (ET) demonstrated a statistically significant and clinically meaningful improvement in OS compared to ET alone in patients with hormone receptor positive
Cleveland Clinic Abu Dhabi, part of the M42 group, has achieved a historic milestone in global healthcare. In collaboration with experts from Cleveland Clinic in the U.S., the team performed the world’s first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer. Focal therapy is a non-invasive treatment that precisely targets a specific
While couples often turn to therapy to reignite their relationships, research suggests travel may be a more effective way to deepen connections. This Valentine’s season, Mazagan Beach & Golf Resort invites couples to break routine and rediscover each other through immersive experiences designed to create lasting memories. Jacques Claudel, General Manager of Mazagan
Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced the successful completion of its acquisition of Dermavant Sciences Ltd. from Roivant (NASDAQ: ROIV). Dermavant is a company dedicated to developing and commercializing innovative therapeutic solutions in immuno-dermatology. Please see our
Researchers explore accelerated version of TMS A groundbreaking therapy that utilises magnetic fields on both sides of the brain has demonstrated effectiveness in swiftly alleviating depression symptoms, particularly for patients who have not responded to traditional treatments. This innovative method, repetitive transcranial magnetic stimulation (TMS), can be administered
















